ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,408Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 298

$554K Total Retail Price of All Prescriptions

Rank: 19 out of 298

443 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,132 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 677 617 1 2
LEVOTHYROXINE SODIUM 449 383 2 1
LISINOPRIL 357 294 3 4
POTASSIUM CHLORIDE 321 282 4 11
OMEPRAZOLE 308 274 5 3
FUROSEMIDE 269 254 6 5
AMLODIPINE BESYLATE 249 224 7 6
METFORMIN HCL 249 210 7 10
ALENDRONATE SODIUM 217 208 9 21
METOPROLOL SUCCINATE 213 210 10 12
TAMSULOSIN HCL 197 179 11 24
WARFARIN SODIUM 187 187 12 7
METOPROLOL TARTRATE 171 156 13 9
CITALOPRAM HBR 169 166 14 17
HYDROCHLOROTHIAZIDE 153 119 15 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 148 148 16 30
CLOPIDOGREL 124 116 17 36
DONEPEZIL HCL 121 121 18 22
CRESTOR 120 104 19 26
ATORVASTATIN CALCIUM 115 107 20 14
ALLOPURINOL 113 95 21 28
ZOLPIDEM TARTRATE 111 89 22 25
GABAPENTIN 109 77 23 20
ATENOLOL 105 101 24 16
SERTRALINE HCL 103 98 25 19
DIGOXIN 93 93 26 27
GLIPIZIDE ER 89 80 27 95
ESCITALOPRAM OXALATE 83 76 28 89
ADVAIR DISKUS 82 66 29 46
ALBUTEROL SULFATE 80 80 30 75
TRIAMTERENE-HCTZ 77 61 31 43
FINASTERIDE 77 75 31 66
ZETIA 76 68 33 83
NEXIUM 76 66 33 40
LOSARTAN POTASSIUM 75 48 35 18
PREDNISONE 75 65 35 33
HYDROCODONE-ACETAMINOPHEN 73 59 S3 37 8
NAMENDA 72 72 38 35
AMITRIPTYLINE HCL 71 41 R 39 51
PLAVIX 71 68 39 70
CYMBALTA 66 34 41 67
CIPROFLOXACIN HCL 65 60 42 56
TRAMADOL HCL 62 60 43 15
CARVEDILOL 60 60 44 23
DIOVAN 60 56 44 47
GLYBURIDE 58 58 R 46 76
DOXAZOSIN MESYLATE 57 50 47 77
LANTUS 56 41 48 53
FLUOXETINE HCL 53 38 49 50
PANTOPRAZOLE SODIUM 51 47 50 110
EVISTA 51 44 50 134
DILTIAZEM 24HR CD 50 50 52 74
PAROXETINE HCL 50 49 52 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.